These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 398985)

  • 1. Acetylsalicylic acid augments insulin and C-peptide responses to arginine in diabetes mellitus.
    Giugliano D; Cacciapuoti F; Varricchio M
    Prostaglandins Med; 1979 Feb; 2(2):109-10. PubMed ID: 398985
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring.
    Ahrén B; Scherstén B; Agardh CD; Lundquist I
    Acta Med Scand; 1981; 210(5):337-48. PubMed ID: 7039239
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypoglycemia-induced inhibition of insulin secretion in metabolically healthy subjects, in diabetics and in patients with adrenalectomy].
    Krause U; Faisst G; Cordes U; Beyer J
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1391-3. PubMed ID: 611850
    [No Abstract]   [Full Text] [Related]  

  • 5. The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.
    Elkeles RS; Heding LG; Paisey RB
    Diabetes Care; 1982; 5(4):427-9. PubMed ID: 6759080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
    Luyckx AS; Mendoza E; Lefebvre PJ
    Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C-peptide secretion dependent on serum glucose and insulin secretion - autoregulation of insulin secretion].
    Zilker T; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1385-8. PubMed ID: 347780
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell function.
    Seigler DE; Reeves ML; Skyler JS
    Diabetes Care; 1982; 5(3):334-6. PubMed ID: 6756843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired insulin secretion in human diabetes mellitus. II. A possible role for prostaglandins.
    Giugliano D; Sgamboto S; Coppola L; Misso L; Torella R
    Prostaglandins Med; 1981 Jan; 6(1):41-50. PubMed ID: 6784135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide in conditions other than diabetes mellitus.
    Horwitz DL; Rubenstein AH; Mako ME; Cruz A; Blix PM
    Diabetes; 1978; 27 Suppl 1():267-71. PubMed ID: 631444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
    Almér LO; Johansson E; Melander A; Wåhlin-Boll E
    Acta Med Scand Suppl; 1981; 656():11-8. PubMed ID: 7046346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins, glucose homeostasis, and diabetes mellitus.
    Robertson RP
    Annu Rev Med; 1983; 34():1-12. PubMed ID: 6344749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lysine acetyl-salicylate on glucose and arginine stimulated insulin release in man.
    van Haeften TW; Veneman TF; van der Veen EA
    Horm Metab Res; 1991 Apr; 23(4):168-70. PubMed ID: 1908430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of endogenous insulin secretion after acute hypoglycaemia in man [proceedings].
    Corrall RJ; Frier BM; Crothers D; Baird JD
    J Endocrinol; 1979 May; 81(2):157P. PubMed ID: 458335
    [No Abstract]   [Full Text] [Related]  

  • 20. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.